These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35158976)
1. Development of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis. Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158976 [TBL] [Abstract][Full Text] [Related]
2. The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort Study. Schut AW; Timbergen MJM; Lidington E; Grünhagen DJ; van der Graaf WTA; Sleijfer S; van Houdt WJ; Bonenkamp JJ; Younger E; Dunlop A; Jones RL; Verhoef C; Gennatas S; Husson O Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206149 [TBL] [Abstract][Full Text] [Related]
3. Unraveling Desmoid-Type Fibromatosis-Specific Health-Related Quality of Life: Who Is at Risk for Poor Outcomes. Schut AW; Lidington E; Timbergen MJM; Younger E; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Verhoef C; Gennatas S; Husson O Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740642 [TBL] [Abstract][Full Text] [Related]
4. Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use. Schut AW; de Bruin LE; de Rooij BH; Lidington E; Timbergen MJM; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Gennatas S; Verhoef C; Husson O Cancer Med; 2023 Jun; 12(12):13661-13674. PubMed ID: 37119048 [TBL] [Abstract][Full Text] [Related]
5. Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study. Timbergen MJM; van de Poll-Franse LV; Grünhagen DJ; van der Graaf WT; Sleijfer S; Verhoef C; Husson O Qual Life Res; 2018 Dec; 27(12):3097-3111. PubMed ID: 30014458 [TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosis. Garg V; Rastogi S; Kalra K; Bhoriwal S; Barwad A; Dhamija E; Upadhyay A; Gamangatti S Support Care Cancer; 2022 Dec; 30(12):10089-10098. PubMed ID: 36350382 [TBL] [Abstract][Full Text] [Related]
7. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study. Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ; Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338 [TBL] [Abstract][Full Text] [Related]
8. The EORTC QLQ-OH17: a supplementary module to the EORTC QLQ-C30 for assessment of oral health and quality of life in cancer patients. Hjermstad MJ; Bergenmar M; Fisher SE; Montel S; Nicolatou-Galitis O; Raber-Durlacher J; Singer S; Verdonck-de Leeuw I; Weis J; Yarom N; Herlofson BB Eur J Cancer; 2012 Sep; 48(14):2203-11. PubMed ID: 22572480 [TBL] [Abstract][Full Text] [Related]
9. Assessing the Desmoid-Type Fibromatosis Patients' Voice: Comparison of Health-Related Quality of Life Experiences from Patients of Two Countries. Timbergen MJM; van der Graaf WTA; Grünhagen DJ; Younger E; Sleijfer S; Dunlop A; Dean L; Verhoef C; van de Poll-Franse LV; Husson O Sarcoma; 2020; 2020():2141939. PubMed ID: 32774131 [TBL] [Abstract][Full Text] [Related]
10. Health-related Quality of Life of Patients With Non-Intra-abdominal Desmoid-Type Fibromatosis During Active Surveillance: Results of a Prospective Observational Study. Schut AW; Timbergen MJM; Nasserinejad K; van Dalen T; van Houdt WJ; Bonenkamp JJ; Sleijfer S; Grünhagen DJ; Verhoef C; Husson O; Ann Surg; 2023 Jun; 277(6):877-883. PubMed ID: 36727954 [TBL] [Abstract][Full Text] [Related]
11. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer. Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366 [TBL] [Abstract][Full Text] [Related]
12. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-c30): validation of English version in Singapore. Luo N; Fones CS; Lim SE; Xie F; Thumboo J; Li SC Qual Life Res; 2005 May; 14(4):1181-6. PubMed ID: 16041912 [TBL] [Abstract][Full Text] [Related]
13. A brief instrument to measure health-related quality-of-life in patients with bone metastasis: validation of the German version of Bone Metastases Quality-of-Life-10 (BOMET-QoL-10). Marschner N; Wilke J; Reschke D; Kaiser F; Schmoor C; Grugel R; Boller E J Med Econ; 2018 Sep; 21(9):920-929. PubMed ID: 29874105 [TBL] [Abstract][Full Text] [Related]
14. Translation and validation of the Urdu version of the European organization for research and treatment of cancer core quality of life questionnaire (EORTC QLQ-C30) and brain module (QLQ-BN20) in primary brain tumor patients. Zahid N; Martins RS; Zahid W; Khalid W; Azam I; Bhamani SS; Asad N; Ahmad K; Jabbar AA; Shamim MS; Khan RJ; Javed G; Bari E; Enam SA J Patient Rep Outcomes; 2021 Sep; 5(1):79. PubMed ID: 34487251 [TBL] [Abstract][Full Text] [Related]
15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
16. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898 [TBL] [Abstract][Full Text] [Related]
17. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III. Niedeggen C; Singer S; Groth M; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J Ann Hematol; 2019 Jul; 98(7):1547-1559. PubMed ID: 31115593 [TBL] [Abstract][Full Text] [Related]
18. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Tan ML; Idris DB; Teo LW; Loh SY; Seow GC; Chia YY; Tin AS Asia Pac J Oncol Nurs; 2014; 1(1):22-32. PubMed ID: 27981079 [TBL] [Abstract][Full Text] [Related]
19. The validation of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30) in pre-operative patients with brain tumor in China. Cheng JX; Liu BL; Zhang X; Zhang YQ; Lin W; Wang R; Zhang YQ; Zhang HY; Xie L; Huo JL BMC Med Res Methodol; 2011 Apr; 11():56. PubMed ID: 21513533 [TBL] [Abstract][Full Text] [Related]
20. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients. Kontodimopoulos N; Ntinoulis K; Niakas D Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]